story of the week
Adding Immunotherapy to Chemo Ups Survival in Advanced Biliary Tract Cancer
Overall survival, progression-free survival prolonged in those receiving durvalumab versus placebo in addition to gemcitabine and cisplatin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.